Emily’s Entourage Funds Synthetic Biology Approach to Enable Durable Gene Therapy for Cystic Fibrosis
Engineered synthetic receptor technology aims to selectively expand corrected airway stem cells and improve long-term treatment durability. Lower Merion, PA—August 13, 2026—Emily’s... Read More
Emily’s Entourage Awards New Funding to University of Texas at Austin to Advance Breakthrough Gene Editing Therapy for Hard-to-Treat Cystic Fibrosis Mutations
With support from Emily’s Entourage, new retron editor technology aims to restore lung function for the 10% of people with cystic fibrosis... Read More
